Cargando…
The impact of chronic use of prostaglandin analogues on the biomechanical properties of the cornea in patients with primary open-angle glaucoma
AIMS: To determine the influence of prostaglandin analogues (PGAs) on corneal biomechanical properties in patients undergoing chronic treatment for primary open-angle glaucoma (POAG). METHODS: Prospective, interventional case–control study. 70 eyes from 35 patients with POAG on chronic PGA therapy w...
Autores principales: | Meda, Roman, Wang, Qianqian, Paoloni, David, Harasymowycz, Paul, Brunette, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293847/ https://www.ncbi.nlm.nih.gov/pubmed/27162226 http://dx.doi.org/10.1136/bjophthalmol-2016-308432 |
Ejemplares similares
-
Prostaglandin analogues in angle closure glaucoma
por: Gupta, Pulkit, et al.
Publicado: (2011) -
The effect of prostaglandin analogs on the biomechanical properties and central thickness of the cornea of patients with open-angle glaucoma: a 3-year study on 108 eyes
por: Tsikripis, Panagiotis, et al.
Publicado: (2013) -
Effect of prostaglandin analogues on anterior scleral thickness and corneal thickness in patients with primary open-angle glaucoma
por: Park, Ji-Hye, et al.
Publicado: (2021) -
Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: A meta-analysis
por: Tang, Wenquan, et al.
Publicado: (2019) -
Efficacy and safety of prostaglandin analogues in patients with predominantly primary open-angle glaucoma or ocular hypertension: a meta-analysis
por: Eyawo, Oghenowede, et al.
Publicado: (2009)